MTP

Midatech Pharma PLC

NASDAQ

Add Alert

MTP

Midatech Pharma PLC

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

Surfacetite Free

06/17/21 6:43 PM

Post #567

Picked some up.

Pedro2004

06/17/21 1:44 PM

Post #566

Re: #565: @kukadu - $3.63 very nice

I have been watching this all day. And I don't know where the shares are coming from.

kukadu

06/17/21 5:34 AM

Post #565

Re: #563: @wesley_ - $3.30 nice

$3.63 very nice

Johnny blaze80 Free

05/18/21 9:21 PM

Post #564

Re: #561: @madras50 - good grief. 1500? what do they have

They actually do have a childrens brain cancer treatment. Also dissolvable tabs for diabetic treatment. Plus a few other big things.

wesley_

02/04/21 12:23 PM

Post #563

$3.30 nice

stock1ace1 Free

01/07/21 8:30 PM

Post #562

Re: #561: @madras50 - good grief. 1500? what do they have

Haha i dont no just thought it was funny gotta love these analyst

madras50

01/07/21 6:42 PM

Post #561

Re: #560: @stock1ace1 - MTP $2.15 ~> $1,500 Price Target Read ~> Google

good grief. 1500? what do they have cure for cancer? I mean 1500 Wtf? just asking

stock1ace1 Free

01/07/21 5:03 PM

Post #560

Re: #552: @ClayTrader - * * $MTP Video Chart 08-14-2020 * *

MTP $2.15 ~> $1,500 Price Target Read ~>

Google (mtp forecast or mtp price target)

Midatech Pharma PLC (NASDAQ:MTP)
The 1 analysts offering 12-month price forecasts for Midatech Pharma PLC have a median target of 1,574.74, with a high estimate of 1,574.74 and a low estimate of 1,574.74. The median estimate represents a +80,655.90% increase from the last price of 1.95.

stock1ace1 Free

01/05/21 11:34 AM

Post #559

Re: #537: @TFMG - $MTP / #MidatechPharma Bullish Move Above 200MA

Mtp $2.25 going

stock1ace1 Free

01/04/21 3:00 PM

Post #558

Re: #537: @TFMG - $MTP / #MidatechPharma Bullish Move Above 200MA

Could go parabolic anyday

stock1ace1 Free

01/04/21 1:21 PM

Post #557

Re: #520: @georgie18 - MTP...$2.95...Psar flipped to a Bullish Buy Position on

Going green MTP $1.88 ~> https://stockcharts.com/h-sc/ui?s=Mtp

ClayTrader Free

10/19/20 5:35 PM

Post #556

* * $MTP Video Chart 10-19-2020 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

08/21/20 4:11 PM

Post #555

* * $MTP Video Chart 08-21-2020 * *

Link to Video - click here to watch the technical chart video

Dubster watching Free

08/21/20 2:59 PM

Post #554

Re: #553: @ROCKY LEDGE - Why don't your recent posts here show on

Not sure

ROCKY LEDGE Free

08/21/20 2:58 PM

Post #553

Re: #550: @Dubster watching - I own quite a few of these great

Why don't your recent posts here show on your profile?

ClayTrader Free

08/14/20 5:57 PM

Post #552

* * $MTP Video Chart 08-14-2020 * *

Link to Video - click here to watch the technical chart video

Dubster watching Free

08/14/20 9:42 AM

Post #551

Sold! Up 100% today and climbing!
God is good

Dubster watching Free

07/30/20 3:13 PM

Post #550

Re: #549: @waytoorandom - Over 100 million shares were bought here on

I own quite a few of these great big upswing candidates that almost seem like no one knows about.

waytoorandom Free

07/30/20 3:02 PM

Post #549

Re: #548: @Dubster watching - So oversold I think. One spec of investor

Over 100 million shares were bought here on the way up

The OS is only 7 million-ish

Dubster watching Free

07/30/20 2:57 PM

Post #548

Re: #547: @waytoorandom - Nah the shorts haven’t filled yet. In my

So oversold I think. One spec of investor attention might help change course.

My worst performer atm.
Fell off a cliff before I bought but caught the falling knife as they say for a bit.
I’ll hold. I didn’t load so much that I’m worried.
Hopeful however. I was just flipping it anyway.

waytoorandom Free

07/30/20 2:52 PM

Post #547

Re: #546: @Dubster watching - Time for this beast to turn UP! Loaded

Nah the shorts haven’t filled yet. In my calculation they have about 90 million plus short sold shares they need to cover before they will allow this to move up again

Thanks Clay Trader you criminal I hope the SEC catches up to you and your “followers” eventually

Dubster watching Free

07/30/20 10:25 AM

Post #546

Time for this beast to turn UP!
Loaded

waytoorandom Free

07/27/20 12:38 PM

Post #545

How long will it take for Clay and his goons to cover their short positions on this?

BEIJING BILL Free

07/22/20 2:25 PM

Post #544

Re: #542: @the_stockoracle - I’m a swing trader so I won’t be

Yu sell .0014 or so

Ocn

Azrx did vell as vell

waytoorandom Free

07/22/20 1:57 PM

Post #543

If it wasn’t for short selling this would be at $10

There’s no way we had volume of 200 million on a OS of 7 million without major manipulation

the_stockoracle Free

07/22/20 11:09 AM

Post #542

Re: #541: @BEIJING BILL - Onyl thing i dunt like on ocn is

I’m a swing trader so I won’t be in it that long just bought in this morning on GTEH at .0012

BEIJING BILL Free

07/22/20 10:01 AM

Post #541

Re: #540: @the_stockoracle - I don’t like the chart of AZRX I

Onyl thing i dunt like on ocn is they voted for reversal split in early augest.

So this is trede only, no long

the_stockoracle Free

07/22/20 9:51 AM

Post #540

Re: #539: @BEIJING BILL - Guud trede

I don’t like the chart of AZRX I like OCN better

BEIJING BILL Free

07/22/20 9:46 AM

Post #539

Re: #538: @the_stockoracle - Perfect sell I sold after it crossed my

Guud trede

I vatching ocn, azrx for 112 breek, bngo

the_stockoracle Free

07/22/20 9:44 AM

Post #538

Re: #532: @BEIJING BILL - Thes stok hit my scenner this morning. I

Perfect sell I sold after it crossed my 5min moving average any other stocks on your radar today

TFMG

07/21/20 7:52 PM

Post #537

$MTP | #MidatechPharma Bullish Move Above 200MA

Awaiting a possible breakout above the 200ma
Huge upside potential
Company Profile
Midatech Pharma Plc commercializes oncology treatments and cancer supportive care products through its U.S. commercial organization, Midatech Pharma US. The company engages in the development of pharmaceutical products utilizing its nanomedicine and sustained release technologies. Its pipeline includes MTD119, MTX102, MTD201 and MTX110. Midatech Pharma was founded on September 12, 2014 and is headquartered in Cardiff, the United Kingdom.

waytoorandom Free

07/21/20 6:56 PM

Post #536

The OS is only 7 million ADSs how the hell were there 200 million traded today!?!?!

Freaking short sellers! It should be ILLEGAL

waytoorandom Free

07/21/20 6:36 PM

Post #535

What a drop from a high of .07.....

waytoorandom Free

07/21/20 4:52 PM

Post #534

Oh geeez Louise here comes Clay

ClayTrader Free

07/21/20 4:16 PM

Post #533

* * $MTP Video Chart 07-21-2020 * *

Link to Video - click here to watch the technical chart video

BEIJING BILL Free

07/21/20 1:09 PM

Post #532

Re: #529: @the_stockoracle - What’s the story here

Thes stok hit my scenner this morning. I buy at 3 dolo and sell for 5.49

Maybe higher maybe lower from here it depends on how merket close.

GoldiS

07/21/20 12:11 PM

Post #531

Re: #530: @the_stockoracle - What’s the story here

https://www.biospace.com/article/releases/midatech-pharma-plc-announces-collaboration-for-the-q-sphera-platform/

the_stockoracle Free

07/21/20 11:28 AM

Post #530

Re: #527: @GoldiS - Wow nice move today

What’s the story here

the_stockoracle Free

07/21/20 11:28 AM

Post #529

Re: #526: @BEIJING BILL - 200 purcent here. Holy chow.

What’s the story here

stoxjock

07/21/20 11:14 AM

Post #528

Did they allow Robinhood traders to trade this or what? I know there was news but news has been trickling for last one month, from what I see.. I rally missed this one but will wit for a sub-$4.00 entry.

GoldiS

07/21/20 10:30 AM

Post #527

Wow nice move today

BEIJING BILL Free

07/21/20 10:10 AM

Post #526

200 purcent here. Holy chow.

waytoorandom Free

07/21/20 10:03 AM

Post #525

Isn’t this a 20 share ADR?

waytoorandom Free

07/21/20 6:54 AM

Post #524

Wow

waytoorandom Free

07/17/20 12:20 PM

Post #523

http://www.midatechpharma.com/uploads/investor_files/Annual%20Report%202019.pdf

rocketrice Free

06/23/20 11:12 AM

Post #522

Time to get in

BeWater

06/19/20 9:07 AM

Post #521

Not 1, but 2 international patents approved! No news release yet either :)

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020120785&tab=NOTICES

&

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020120787

georgie18

05/01/20 5:18 AM

Post #520

MTP...$2.95...Psar flipped to a Bullish Buy Position on the volume spike...
MTP is an ADR not common shares...treat it accordingly...

Chart...http://schrts.co/wWnqidqU

scotsand

03/11/20 7:25 PM

Post #519

Why did I sell again?

waytoorandom Free

03/04/20 9:14 AM

Post #518

Re: #517: @scotsand - I thought I read something about the ADR

The ADR ratio change was a while ago

Did this just go from .50 to $3 two days ago and I totally missed it?

I have been out for some time here

Older

Midatech Pharma PLC (MTP)

Followers	13	Posters	88
Posts (Today)	0	Posts (Total)	567
Created	03/28/16	Type	Free
Moderators

5 Marketed Products + Oral thin-film Insulin with P2 Results in April which has Multiple Blockbuster Potential and many other drugs in clinical Trials . this undiscovered low float stock is brutally undervalued alone the marketed drugs will drive this Company into profitability within 2 years . If the Phase 2 results of the Oral Insulin in April is positive then this low float stock could explode like Oramed (ORMP) did in end 2013 to early 2014 which send the stock from $10 to almost $30 within days .

This Undiscovered Stock with a Market Cap of less than $60 Million and over $30 Million in Cash is heavily underpriced but this will Change very soon especially when the Outcome of the Oral Insulin is positive .GL

Midatech Pharma (MTP)

Market Cap: $59.5 Million
Cash: $35 Million
Price: $3.58

Shares Out: 16.6 Million

MidatechPharma US: Focus On Oncology and Supportive Care:

Zuplenz: Oral film for Chemo/Radio Rx Induced Nausea & Vomiting Highly effective 5HT3 antagonist Launch H1 2016

Gelclair: Hyaluronic Acid Oral Gel For Oral Mucositis 85-100% of H&N cancer patients on chemo/radiotherapy develop OM Leads market in US strong growth expected 2016

Aquoral:Oral Spray Treatment For Dry Mouth Xerostomia

Oravig:Buccal Tablet For Oral Candidiasis In Adults Serious complication for patients undergoing radio/chemotherapy Launched H2 2015 –first full year of sales 2016

Ferralet90: Dual Iron Delivery Anaemia treatment

Oral thin-film Insulin:

From positive Phase I clinical trial results it has been demonstrated that the transbuccal insulin formulation is safe and well tolerated in healthy human volunteers and that it is absorbed faster and utilised more quickly than subcutaneous insulin.

•Phase I (2012) -No safety concerns
-Suggests insulin enters blood, faster to max effect

•Phase IIa-Completed in life phase January 2016
-Clinical Study Report is expected in April 2016

•Phase II data will inform strategic opportunities (license or exit)

“Diabetes incidence is forecast to hit 500m people, globally, by 2025; with our partnered transbuccal insulin strip, MSL-001 is targeting a $20 billion market, adding significant revenue potential to our growing portfolio of products.”

Jim Phillips Presents on behalf of Midatech Pharma at the Biotech Capital Conference
https://www.youtube.com/watch?v=GrrfbLeJWpU

March Presentation
http://www.midatechpharma.com/uploads/Midatech%20Deck%202016%20march%2003%20Com.pdf

Major shareholders
http://www.midatechpharma.com/investors/share-information.html

Edison Research
http://www.edisoninvestmentresearch.com/research/report/midatech4/preview/

Valuation: Increased to $221.0m from $200.7m

Our valuation for Midatech increases to $221.0m from $200.7m previously (or $13.29/ADR from $14.45/ADR, as we now incorporate the acquisitions of DARA and Zuplenz. Our valuation for DARA is based on forecast future operating cash flows (excluding potential payments on contingent value rights that are dependent on sales milestones, which exceed our relatively conservative projections). Additionally, we adjust our valuation for Midatech upward as our model has been rolled forward by six months and rebased to 2016.